Long-term efficacy and safety follow-up of MLD patients treated with atidarsagene autotemcel (LongTERM-MLD)

07/09/2022
12/12/2025
EU PAS number:
EUPAS48374
Study
Ongoing
Documents
Study protocol
Study results
Study report
Other information